Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Guardant Health Q3 Revenues Spike 181 Percent

Guardant Health Q3 Revenues Spike 181 Percent

Nov 07, 2019
|
staff reporter

NEW YORK  – Guardant Health reported after the close of the market on Thursday that its third quarter 2019 revenues more than doubled year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Finds a Whole Bunch

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Away From the Field

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

PNAS Studies Look at Bacterial Detection Probes, Cholera Culprit Evolution in Environment, More

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. Qiagen Receives FDA Emergency Use Authorization for SARS-CoV-2 Respiratory Panel

  2. Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies

  3. Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test

  4. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  5. Exact Sciences, Promega Aiding in COVID-19 Testing in Wisconsin

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.